
Case Study Biodimed
Support for a Biotech Company entering the french market with an orphan drug.
Support for a Biotech Company entering the french market with an orphan drug.
Support for a Biotech Company entering the french market with an orphan drug.
RPN has experience with a wide range of therapeutic areas and particularly with orphan and advanced-therapy medicinal products. RPN support includes early access and P&MA strategic assessments, advisory boards, stakeholder management and full support with national and regional P&R negotiations.
SmartStep Healthcare Strategy & Market Access Consulting provides personalized and specialized consulting services to the pharmaceutical and medical device industries to provide fast and effective market access to their products in Germany.